Introduction: Deep brain stimulation of the subthalamic nucleus (STN-DBS) can exert relevant effects on the voice of patients with Parkinson's disease (PD). In this study, we used artificial intelligence to objectively analyze the voices of PD patients with STN-DBS.
Materials And Methods: In a cross-sectional study, we enrolled 108 controls and 101 patients with PD.
Speaker Recognition (SR) is a common task in AI-based sound analysis, involving structurally different methodologies such as Deep Learning or "traditional" Machine Learning (ML). In this paper, we compared and explored the two methodologies on the DEMoS dataset consisting of 8869 audio files of 58 speakers in different emotional states. A custom CNN is compared to several pre-trained nets using image inputs of spectrograms and Cepstral-temporal (MFCC) graphs.
View Article and Find Full Text PDFParkinson's Disease (PD) is one of the most common non-curable neurodegenerative diseases. Diagnosis is achieved clinically on the basis of different symptoms with considerable delays from the onset of neurodegenerative processes in the central nervous system. In this study, we investigated early and full-blown PD patients based on the analysis of their voice characteristics with the aid of the most commonly employed machine learning (ML) techniques.
View Article and Find Full Text PDFMachine Learning (ML) algorithms within a human-computer framework are the leading force in speech emotion recognition (SER). However, few studies explore cross-corpora aspects of SER; this work aims to explore the feasibility and characteristics of a cross-linguistic, cross-gender SER. Three ML classifiers (SVM, Naïve Bayes and MLP) are applied to acoustic features, obtained through a procedure based on Kononenko's discretization and correlation-based feature selection.
View Article and Find Full Text PDFMany virological tests have been implemented during the Coronavirus Disease 2019 (COVID-19) pandemic for diagnostic purposes, but they appear unsuitable for screening purposes. Furthermore, current screening strategies are not accurate enough to effectively curb the spread of the disease. Therefore, the present study was conducted within a controlled clinical environment to determine eventual detectable variations in the voice of COVID-19 patients, recovered and healthy subjects, and also to determine whether machine learning-based voice assessment (MLVA) can accurately discriminate between them, thus potentially serving as a more effective mass-screening tool.
View Article and Find Full Text PDF